Genmab A/S (NASDAQ:GMAB) Q2 2024 Earnings Call Transcript
Operator: Hello, and welcome to the Genmab First Half 2024 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Genmab A/S (GMAB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 1,462,459 | $36,751,595 | +8% | 0.06% |
| 2. | Citadel Investment Group Ken Griffin | 1,270,888 | $31,937,416 | +2541% | 0% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 648,379 | $16,293,764 | -32% | 0.02% |
| 4. | Millennium Management Israel Englander | 380,995 | $9,574,404 | -20% | 0% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 334,200 | $8,398,446 | +484% | 0.01% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 15,614,510 | $497,165,998 | 0.19% | |
| 2. | 4,409,575 | $140,400,861 | 0% | |
| 3. | 4,057,922 | $129,650,575 | 0.02% | |
| 4. | 3,289,895 | $97,568,587 | 0.54% | |
| 5. | 2,369,331 | $75,439,498 | 0.01% |
News See All
Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Genmab A/S (NASDAQ:GMAB) Q4 2023 Earnings Call Transcript
Genmab A/S misses on earnings expectations. Reported EPS is $0.14 EPS, expectations were $0.35.
12 High Growth International Stocks to Buy
In this article, we discuss the 12 high growth international stocks to buy.
Genmab A/S (NASDAQ:GMAB) Q3 2023 Earnings Call Transcript
Operator: Hello, and welcome to Genmab's Third Quarter 2023 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Genmab A/S (NASDAQ:GMAB) Q2 2023 Earnings Call Transcript
Operator: Hello, and welcome to Genmab's Second Quarter 2023 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Genmab A/S (NASDAQ:GMAB) Q1 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Genmab's First Quarter 2023 Financial Results Conference Call. As a reminder, this conference call is being recorded.
15 Most Profitable Growth Stocks Now
Growth stocks refer to listed companies that are growing their profits, revenue, or cash flow at a rate that exceeds their competitors and beats the overall market.
Billionaire Hedge Funds
